Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 14951 - 14960 of 24215
| Identification Number | Trade Name | Benefit Category |
|---|---|---|
| 02355337 | APO-IMATINIB TAB 100MG | Standard Benefit for Eligible Clients |
| 02355345 | APO-IMATINIB TAB 400MG | Standard Benefit for Eligible Clients |
| 02355442 | PMS-CELECOXIB CAP 100MG | Standard Benefit for Eligible Clients |
| 02355450 | PMS-CELECOXIB CAP 200MG | Standard Benefit for Eligible Clients |
| 02355469 | GD-CEFPROZIL PWS 125MG/5ML (25MG/ML) | Standard Benefit for Eligible Clients |
| 02355477 | GD-CEFPROZIL PWS 250MG/5ML (50MG/ML) | Standard Benefit for Eligible Clients |
| 02355485 | GD-CEFPROZIL TAB 250MG | Standard Benefit for Eligible Clients |
| 02355493 | GD-CEFPROZIL TAB 500MG | Standard Benefit for Eligible Clients |
| 02355507 | TEVA-MONTELUKAST (CHEWABLE TABLET) 4MG | Standard Benefit for Eligible Clients |
| 02355515 | TEVA-MONTELUKAST (CHEWABLE TABLET) 5MG | Standard Benefit for Eligible Clients |
Displaying 14951 - 14960 of 24215